Kiniksa Pharmaceuticals International, plc
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2017 | $-50.2M | $-50.3M | $69.0K | $897.0K |
| FY2018 | $-81.0M | $-86.3M | $5.3M | $5.7M |
| FY2019 | $-158.4M | $-161.6M | $3.2M | $15.1M |
| FY2020 | $-136.5M | $-136.8M | $283.0K | $20.9M |
| FY2021 | $-126.3M | $-126.7M | $415.0K | $25.2M |
| FY2022 | $5.8M | $5.7M | $105.0K | $25.1M |
| FY2023 | $13.3M | $13.2M | $130.0K | $27.1M |
| FY2024 | $25.7M | $25.4M | $277.0K | $30.7M |
| FY2025 | $138.0M | $136.4M | $1.6M | $37.0M |